Loading...
Tumour heterogeneity and the evolution of polyclonal drug resistance
Cancer drug resistance is a major problem, with the majority of patients with metastatic disease ultimately developing multidrug resistance and succumbing to their disease. Our understanding of molecular events underpinning treatment failure has been enhanced by new genomic technologies and pre‐clin...
Saved in:
| Published in: | Mol Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528620/ https://ncbi.nlm.nih.gov/pubmed/25087573 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.06.005 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|